4.8 Article

When more is less Excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease

Journal

AUTOPHAGY
Volume 5, Issue 1, Pages 111-113

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/auto.5.1.7293

Keywords

Pompe disease; lysosome; muscle-specific autophagy deficiency; protein inclusions

Categories

Funding

  1. National Institute of Arthritis and Musculoskeletal and Skill Diseases of the National Institutes of Health
  2. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041099, ZICAR041186, ZICAR041132] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The role of autophagy, a catabolic lysosome-dependent pathway, has recently been recognized in a variety of disorders, including Pompe disease, which results from a deficiency of the glycogen-degrading lysosomal hydrolase acid-alpha glucosidase (GAA). Skeletal and cardiac muscle are most severely affected by the progressive expansion of glycogen-filled lysosomes. In both humans and an animal model of the disease (GAA KO), skeletal muscle pathology also involves massive accumulation of autophagic vesicles and autophagic buildup in the core of myofibers, suggesting an induction of autophagy. Only when we suppressed autophagy in the skeletal muscle of the GAA KO mice did we realize that the excess of autophagy manifests as a functional deficiency. This failure of productive autophagy is responsible for the accumulation of potentially toxic aggregate-prone ubiquitinated proteins, which likely cause profound muscle damage in Pompe mice. Also, by generating muscle-specific autophagy-deficient wild-type mice, we were able to analyze the role of autophagy in healthy skeletal muscle.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available